108 related articles for article (PubMed ID: 26745095)
1. Aqueous Extract of Anticancer Drug CRUEL Herbomineral Formulation Capsules Exerts Anti-proliferative Effects in Renal Cell Carcinoma Cell Lines.
Verma SP; Sisoudiya S; Das P
Asian Pac J Cancer Prev; 2015; 16(18):8419-23. PubMed ID: 26745095
[TBL] [Abstract][Full Text] [Related]
2. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
3. Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells.
Iwamoto Y; Ishii K; Sasaki T; Kato M; Kanda H; Yamada Y; Arima K; Shiraishi T; Sugimura Y
Cancer Prev Res (Phila); 2013 Sep; 6(9):1000-6. PubMed ID: 23901046
[TBL] [Abstract][Full Text] [Related]
4. Triiodothyronine regulates cell growth and survival in renal cell cancer.
Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
7. NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
Hosono T; Tanaka T; Tanji K; Nakatani T; Kamitani T
Br J Cancer; 2010 Mar; 102(5):873-82. PubMed ID: 20160729
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
9. Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
Hsieh MH; Tsai JP; Yang SF; Chiou HL; Lin CL; Hsieh YH; Chang HR
Cells; 2019 Aug; 8(9):. PubMed ID: 31438640
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
11. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
Mo R; Peng J; Xiao J; Ma J; Li W; Wang J; Ruan Y; Ma S; Hong Y; Wang C; Gao K; Fan J
Tumour Biol; 2016 Jul; 37(7):9797-806. PubMed ID: 26810069
[TBL] [Abstract][Full Text] [Related]
12. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
[TBL] [Abstract][Full Text] [Related]
14. Study on the effects of allitride and its mechanisms on renal cell carcinoma in vitro.
Liu H; Wu RP; Li XF; Cao KY; Li LJ; Zhang W
Urologia; 2011; 78(2):116-22; discussion 123-4. PubMed ID: 21574149
[TBL] [Abstract][Full Text] [Related]
15. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
16. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
[TBL] [Abstract][Full Text] [Related]
17. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase.
Wang LS; Chen SJ; Zhang JF; Liu MN; Zheng JH; Yao XD
BMC Urol; 2017 May; 17(1):38. PubMed ID: 28558682
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
Morais C; Pat B; Gobe G; Johnson DW; Healy H
Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
Woschek M; Kneip N; Jurida K; Marzi I; Relja B
Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]